The European Medicines Agency (EMA) has recommended the use of Pfizer/BioNTech and Moderna vaccines adapted to protect against the Omicron coronavirus strain, the regulator said on Thursday.
The EMA Medicines Committee has recommended that two vaccines adapted for broader protection against COVID-19 be allowed to be used.
It notes that we are talking about vaccines aimed specifically at protecting against “omicron”.
According to the report, studies have shown that adapted versions of the vaccine “induce a strong immune response against Omicron and the original strain of SARS-CoV-2 in people who were previously vaccinated.”
Now the recommendation of the EMA committee will be sent to the European Commission, which “will make a final legally binding decision applicable in all EU member states”
